BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26504400)

  • 1. CXCL12 genetic variants as prognostic markers in nasopharyngeal carcinoma.
    Chen R; Xu Y; Du X; Liu N; Li Y; He Q; Tang L; Mao Y; Sun Y; Chen L; Ma J
    Onco Targets Ther; 2015; 8():2835-42. PubMed ID: 26504400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL12/CXCR4 axis gene variants contribute to an increased vulnerability to HPV infection and cervical oncogenesis.
    Okuyama NCM; Cezar-Dos-Santos F; Trugilo KP; Esposito A; Guembarovski RL; Couto-Filho JD; Watanabe MAE; de Oliveira KB
    J Cancer Res Clin Oncol; 2022 Apr; 148(4):793-802. PubMed ID: 35083551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of rs1801157 single nucleotide polymorphism of CXCL12 gene in breast cancer in Pakistan and
    Khalid S; Hanif R
    PeerJ; 2017; 5():e3822. PubMed ID: 28929029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer.
    Guembarovski AL; Guembarovski RL; Hirata BKB; Vitiello GAF; Suzuki KM; Enokida MT; Watanabe MAE; Reiche EMV
    Mol Biol Rep; 2018 Oct; 45(5):741-750. PubMed ID: 29926386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNP rs1801157 significantly correlates with distant metastasis in CXCL12 expressing esophagogastric cancer.
    Schimanski CC; Jordan M; Schlaegel F; Schmidtmann I; Lang H; Galle PR; Moehler M; Gockel I
    Int J Oncol; 2011 Aug; 39(2):515-20. PubMed ID: 21584490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL12 and CXCR4 polymorphisms and expressions in peripheral blood from patients of hepatocellular carcinoma.
    Qin LF; Qin JM; Zhang JQ; Lv XP; Huang LY; Wang JJ
    Future Oncol; 2018 Jun; 14(13):1261-1271. PubMed ID: 29741398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic variants and immunostaining profile in CXCL12/CXCR4 axis: An investigation of association with prognosis in prostate cancer.
    Francelino AL; Pereira ÉR; Pinheiro LCL; Soares AC; Mendonça AC; Fuganti PE; Frantine-Silva W; de Oliveira KB; Serpeloni JM; Guembarovski RL
    Pathol Res Pract; 2023 Oct; 250():154806. PubMed ID: 37738928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma.
    Mazur G; Gębura K; Gieryng A; Butrym A; Wróbel T; Bogunia-Kubik K
    Cytokine; 2013 Oct; 64(1):422-6. PubMed ID: 23711392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.
    Jiang YP; Wu XH; Shi B; Wu WX; Yin GR
    Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of primary gross tumor volume and standardized uptake value of
    Jin YN; Yao JJ; Wang SY; Zhang WJ; Zhou GQ; Zhang F; Cheng ZB; Ma J; Mo HY; Sun Y
    Tumour Biol; 2017 Jul; 39(7):1010428317717843. PubMed ID: 28671052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of polymorphisms of stromal-derived factor-1 and CXC receptor 4 in acute myeloid leukemia and leukemia cell dissemination.
    Zheng Q; Shuai X; Ye Y; Jin Y; Jiang N; Chen X; Su J
    Gene; 2016 Aug; 588(2):103-8. PubMed ID: 27154815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients.
    de Oliveira KB; Guembarovski RL; Oda JM; Mantovani MS; Carrera CM; Reiche EM; Voltarelli JC; da Silva do Amaral Herrera AC; Watanabe MA
    Cytokine; 2011 Aug; 55(2):260-5. PubMed ID: 21592819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common sequence variants in chemokine-related genes and risk of breast cancer in post-menopausal women.
    Bodelon C; Malone KE; Johnson LG; Malkki M; Petersdorf EW; McKnight B; Madeleine MM
    Int J Mol Epidemiol Genet; 2013; 4(4):218-27. PubMed ID: 24319537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival.
    Wagner PL; Hyjek E; Vazquez MF; Meherally D; Liu YF; Chadwick PA; Rengifo T; Sica GL; Port JL; Lee PC; Paul S; Altorki NK; Saqi A
    J Thorac Cardiovasc Surg; 2009 Mar; 137(3):615-21. PubMed ID: 19258077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance.
    van den Bosch T; Koopmans AE; Vaarwater J; van den Berg M; de Klein A; Verdijk RM
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7354-61. PubMed ID: 24052640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of chemokine receptor CXCR4 is closely correlated with clinical outcome in human nasopharyngeal carcinoma.
    Tao H; Wei Y; Wang C; Yang K; Huang W; Liu H; Li B
    Tumour Biol; 2016 May; 37(5):6099-105. PubMed ID: 26611644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan.
    Lin GT; Tseng HF; Yang CH; Hou MF; Chuang LY; Tai HT; Tai MH; Cheng YH; Wen CH; Liu CS; Huang CJ; Wang CL; Chang HW
    OMICS; 2009 Apr; 13(2):165-72. PubMed ID: 19196101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer.
    Stanisavljević L; Aßmus J; Storli KE; Leh SM; Dahl O; Myklebust MP
    Tumour Biol; 2016 Jun; 37(6):7441-52. PubMed ID: 26678887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.